Published in J Mass Spectrom on February 01, 2005
Bridging neuropeptidomics and genomics with bioinformatics: Prediction of mammalian neuropeptide prohormone processing. J Proteome Res (2006) 1.21
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. J Neural Transm (Vienna) (2006) 0.79
Quantitative Analysis of Staphylococcal Enterotoxins A and B in Food Matrices Using Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-MS/MS). Toxins (Basel) (2015) 0.79
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother (2004) 2.34
Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia (2010) 2.07
Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation. J Proteome Res (2005) 1.84
The proteomic analysis of primary cortical astrocyte cell culture after morphine administration. J Proteome Res (2009) 1.55
A novel pathway for amyloid precursor protein processing. Neurobiol Aging (2009) 1.52
Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res (2007) 1.51
A practical guide to nano-LC troubleshooting. J Sep Sci (2007) 1.44
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients. Neuroreport (2002) 1.35
Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry. J Proteome Res (2006) 1.27
Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci U S A (2011) 1.27
An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid. Neurosci Lett (2006) 1.11
Characterization of tau in cerebrospinal fluid using mass spectrometry. J Proteome Res (2008) 1.09
Methods for samples preparation in proteomic research. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.08
Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci (2003) 1.08
Identification of novel APP/Abeta isoforms in human cerebrospinal fluid. Neurodegener Dis (2009) 1.05
Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. J Psychiatr Res (2004) 1.04
Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord (2009) 1.03
Identification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS method. Neurochem Res (2011) 0.97
Novel biochemical markers of psychosocial stress in women. PLoS One (2009) 0.97
Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress. PLoS One (2009) 0.97
Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur J Pharmacol (2003) 0.96
Acid-labile surfactant assists in-solution digestion of proteins resistant to enzymatic attack. Rapid Commun Mass Spectrom (2004) 0.95
Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease. Neurodegener Dis (2009) 0.94
An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid. J Mass Spectrom (2012) 0.94
The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder. Psychiatry Res (2009) 0.94
Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res Mol Brain Res (2002) 0.93
Rat brain proteome in morphine dependence. Neurochem Int (2006) 0.92
The activity of CART peptide fragments. Peptides (2006) 0.92
N-terminal H3/D3-acetylation for improved high-throughput peptide sequencing by matrix-assisted laser desorption/ionization mass spectrometry with a time-of-flight/time-of-flight analyzer. Rapid Commun Mass Spectrom (2006) 0.91
An enhanced method for peptides sequencing by N-terminal derivatization and MS. Proteomics (2005) 0.90
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease. Brain Res (2013) 0.89
Proteomics in neurosciences. Mass Spectrom Rev (2007) 0.89
Subjective health perception in healthy young men changes in response to experimentally restricted sleep and subsequent recovery sleep. Brain Behav Immun (2013) 0.88
Catecholamines and methods for their identification and quantitation in biological tissues and fluids. J Neurosci Methods (2002) 0.88
Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann Neurol (2007) 0.87
The new face of nucleolin in human melanoma. Cancer Immunol Immunother (2009) 0.87
Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence. Neuroreport (2003) 0.86
Activities of temporin family peptides against the chytrid fungus (Batrachochytrium dendrobatidis) associated with global amphibian declines. Antimicrob Agents Chemother (2003) 0.86
Comparison between choir singing and group discussion in irritable bowel syndrome patients over one year: saliva testosterone increases in new choir singers. Psychother Psychosom (2009) 0.86
Proteomic analysis of striatal neuronal cell cultures after morphine administration. J Sep Sci (2009) 0.85
Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res (2003) 0.84
Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med (2006) 0.84
A novel cryptic peptide derived from the rat neuropeptide FF precursor reverses antinociception and conditioned place preference induced by morphine. Peptides (2007) 0.83
Comparative proteome analysis of thalamus in MK-801-treated rats. Proteomics (2004) 0.83
Proteomics profiling of single organs from individual adult zebrafish. Zebrafish (2010) 0.82
Evaluation of sample fractionation using micro-scale liquid-phase isoelectric focusing on mass spectrometric identification and quantitation of proteins in a SILAC experiment. Rapid Commun Mass Spectrom (2007) 0.82
Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp Neurol (2009) 0.81
Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats. Peptides (2007) 0.81
Sympathetic and sensory nerve activation during negative pressure therapy of sternotomy wounds. Interact Cardiovasc Thorac Surg (2008) 0.81
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry. Neurodegener Dis (2015) 0.80
Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid. Neurodegener Dis (2014) 0.80
Proteome analysis of conditioned medium from cultured adult hippocampal progenitors. Rapid Commun Mass Spectrom (2003) 0.80
Characterisation of a highly specific, endogenous inhibitor of cysteine protease from Staphylococcus epidermidis, a new member of the staphostatin family. Biol Chem (2004) 0.80
Magnetic scavengers as carriers of analytes for flowing atmospheric pressure afterglow mass spectrometry (FAPA-MS). Analyst (2015) 0.79
Morphinome--a meta-analysis applied to proteomics studies in morphine dependence. Proteomics (2010) 0.79
Proteome analysis of mouse primary astrocytes. Neurochem Int (2005) 0.79
Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules. J Biol Chem (2012) 0.79
Molecular scavengers as carriers of analytes for mass spectrometry identification. Anal Chem (2014) 0.79
Direct analysis of methcathinone from crude reaction mixture by flowing atmospheric-pressure afterglow mass spectrometry. Rapid Commun Mass Spectrom (2012) 0.79
The role of neuropeptide FF (NPFF) in the expression of sensitization to hyperlocomotor effect of morphine and ethanol. Neuropeptides (2006) 0.79
Plasma ANP and BNP during exercise in patients with major depressive disorder and in healthy controls. J Affect Disord (2010) 0.78
Antibiotic properties of novel synthetic temporin A analogs and a cecropin A-temporin A hybrid peptide. Protein Pept Lett (2002) 0.78
Cryptic peptide derived from the rat neuropeptide FF precursor affects G-proteins linked to opioid receptors in the rat brain. Peptides (2008) 0.78
Crypteins derived from the mouse neuropeptide FF (NPFF)A precursor display NPFF-like effects in nociceptive tests in mice. Peptides (2012) 0.78
Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception. Neuropeptides (2008) 0.78
Covariation of plasma ghrelin and motilin in irritable bowel syndrome. Peptides (2010) 0.78
Determination of psychostimulants and their metabolites by electrochemistry linked on-line to flowing atmospheric pressure afterglow mass spectrometry. Analyst (2014) 0.77
Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animals. Peptides (2008) 0.77
CART (85-102)-inhibition of psychostimulant-induced hyperlocomotion: importance of cyclization. Peptides (2006) 0.77
Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment. Eur Neuropsychopharmacol (2004) 0.77
Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus. Eur J Intern Med (2009) 0.77
Choir singing and fibrinogen. VEGF, cholecystokinin and motilin in IBS patients. Med Hypotheses (2008) 0.76
Unimpaired postprandial pancreatic polypeptide secretion in Parkinson's disease and REM sleep behavior disorder. Mov Disord (2012) 0.76
A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines. Mol Cell Biochem (2013) 0.76
iTRAQ analysis with Paul ion trap-obstacle solved. J Proteome Res (2013) 0.76
Suicide-attempters having immunoglobulin G with affinity for dopamine in cerebrospinal fluid. Eur Neuropsychopharmacol (2002) 0.76
Differential effects of N-peptidyl-O-acyl hydroxylamines on dynorphin-induced antinociception in the mouse capsaicin test. Neuropeptides (2005) 0.76
Synthesis and characterisation of PEG-peptide surfaces for proteolytic enzyme detection. Anal Bioanal Chem (2013) 0.76
Use of Ubp1 protease analog to produce recombinant human growth hormone in Escherichia coli. Microb Cell Fact (2014) 0.75
Crypteins--an overlooked piece of peptide systems. Curr Protein Pept Sci (2015) 0.75
Differential binding of tropomyosin isoforms to actin modified with m-maleimidobenzoyl-N-hydroxysuccinimide ester and fluorescein-5-isothiocyanate. Anal Biochem (2009) 0.75
Elevated levels of alpha-2-Heremans-Schmid glycoprotein in CSF of patients with low-grade gliomas. Tumour Biol (2003) 0.75
Wrong biochemistry results. Information on incidents with consequences for health should be collected centrally. BMJ (2002) 0.75
Constant activity of glutamine synthetase after morphine administration versus proteomic results. Anal Bioanal Chem (2010) 0.75
Identification of bikunin as an endogenous inhibitor of dynorphin convertase in human cerebrospinal fluid. FEBS J (2006) 0.75
Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice. Neuropeptides (2013) 0.75
Synthesis of metabolites of paracetamol and cocaine via photooxidation on TiO2 catalyzed by UV light. J Photochem Photobiol B (2012) 0.75
Fingerprinting of 3, 4-methylenedioxymethamphetamine markers by desorption/ionization on porous silicon. Eur J Mass Spectrom (Chichester, Eng) (2006) 0.75
Dynorphin convertases and their functions in CNS. Curr Pharm Des (2013) 0.75